98%
921
2 minutes
20
Background: Blunt traumatic thoracic aortic injury (BTAI) is considered a life-threatening surgical emergency. Thoracic endovascular aortic repair (TEVAR) has significantly improved survival rates and reduced complications. The patients are typically young and present with normal aortic diameter. Often, there is a discrepancy in diameter between commercially available "off-the-shelf" thoracic aortic endografts and the diameter of the aorta.
Methods: We performed a retrospective study examining short-term outcomes of TEVAR oversizing for BTAI patients at our institution from 2004 to 2024. The primary outcome was procedural success, while secondary outcomes included endoleak, graft occlusion, and reintervention.
Results: A total of thirty-three cases involving BTAI were managed by TEVAR, with a mean age of 48.9±19.4 years. The injury severity score averaged 29.1±9.6 points. Most cases were grade 3 BTAI, accounting for 87.9%. The mean aortic diameter at the proximal landing zone was 24.4±3.6 mm, and the distal zone was 22.5±4.0 mm. Proximal stent oversizing was 31.9±4.1%, and the distal was 28.5±4.1%. All cases achieved procedural success. One case involved an early retrograde aortic dissection that required subsequent proximal extension, while another case presented an endoleak originating from the left subclavian branch, necessitating subclavian embolization and a bypass from the left carotid to the subclavian artery. No graft occlusions were reported.
Conclusions: The oversized TEVAR procedure may be performed under emergency conditions of BTAI, providing life-saving benefits with acceptable early outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.23736/S0021-9509.25.13304-1 | DOI Listing |
Int Heart J
September 2025
Department of Cardiovascular Surgery, West China Hospital, Sichuan University.
Although several observational studies have suggested an association between plasma homocysteine (Hcy), vitamin B12, and folate levels and aortic diseases, including aortic dissection (AD), thoracic aortic aneurysm (TAA), and abdominal aortic aneurysm (AAA), the causality remains unclear. The aortic diameter was also included in the analysis. Therefore, this study employed Mendelian randomization (MR) analysis to investigate the effects of plasma Hcy, vitamin B12, and folate levels on aortic diseases.
View Article and Find Full Text PDFEur J Vasc Endovasc Surg
September 2025
Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany.
Objective: This study aimed to evaluate treatment indications, compare therapeutic approaches, and assess outcomes in patients with infrarenal penetrating aortic ulcers (iPAUs).
Methods: This was a retrospective, multicentre, observational study of patients with iPAUs treated between January 2018 and December 2022 across 12 European centres. Treatment strategies included open surgical repair (OSR) and endovascular techniques, including balloon expandable stent grafts (BESGs), covered endovascular reconstruction of the aortic bifurcation (CERAB), and endovascular aortic repair (EVAR) using bifurcated or tube grafts.
Eur J Vasc Endovasc Surg
September 2025
Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Objective: This study aimed to use quantitative magnetic resonance angiography (qMRA) to investigate the haemodynamic influences on cerebral circulation after hybrid thoracic endovascular aortic repair (TEVAR).
Methods: Between January 2016 and October 2019, zone 1 and 2 TEVAR with supra-arch rerouting procedure in extra-anatomical fashion was performed in 24 patients (mean age 72.9 ± 11.
J Thorac Cardiovasc Surg
September 2025
Division of Cardiac Surgery, Department of Surgery, University of Manitoba, Winnipeg, MB, Canada. Electronic address:
Introduction: The impact of sex on quality of life (QoL) and long-term mortality after thoracic aortic surgery is incompletely understood. We investigated whether sex-related differences in these outcomes exist following surgery.
Methods: Patients undergoing thoracic aortic surgery between 2004-2023 were identified using the Manitoba Thoracic Aortic Database, which was linked to population-level registries in the Manitoba Centre for Health Policy.
J Thorac Cardiovasc Surg
September 2025
Population Health Research Institute, Hamilton Health Sciences, McMaster University, Ontario, Canada.
Objective: Societal guidelines recommend vitamin K antagonists (VKAs) for atrial fibrillation patients with recent biological valve implantation, but the safety and efficacy of direct oral anticoagulants (DOACs) in this setting remain uncertain, especially in the early postoperative period. This substudy of the Left Atrial Appendage Occlusion Study (LAAOS) III trial aimed to compare thromboembolic and bleeding outcomes in patients discharged on VKAs versus DOACs after bioprosthesis implantation or mitral valve repair.
Methods: A total of 2,645 patients were included, with 461 discharged on DOACs and 2184 on VKAs.